Lenabasum, a cannabinoid receptor agonist, is an effective and safe treatment for amyopathic…
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. This phase 2…